ARCHIVES

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

July 29, 2005

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

Wistar’s Koprowski; Rivera Is Director

April 12, 1991

NIH funds four centers to study breast cancer and the environment.

October 17, 2003

Upton Explains New NCI System: Rants Funded “Across The Board” Strictly By Priority Score

August 25, 1978